These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27357860)

  • 1. Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR-Cas9 library.
    Wu Y; Kang T
    Chin J Cancer; 2016 Jun; 35(1):60. PubMed ID: 27357860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A.
    Wu Y; Zhou L; Wang X; Lu J; Zhang R; Liang X; Wang L; Deng W; Zeng YX; Huang H; Kang T
    Cell Discov; 2016; 2():16014. PubMed ID: 27462461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 technology: applications and human disease modelling.
    Torres-Ruiz R; Rodriguez-Perales S
    Brief Funct Genomics; 2017 Jan; 16(1):4-12. PubMed ID: 27345434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.
    Barrangou R; Birmingham A; Wiemann S; Beijersbergen RL; Hornung V; Smith Av
    Nucleic Acids Res; 2015 Apr; 43(7):3407-19. PubMed ID: 25800748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
    Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
    Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dual-reporter system for real-time monitoring and high-throughput CRISPR/Cas9 library screening of the hepatitis C virus.
    Ren Q; Li C; Yuan P; Cai C; Zhang L; Luo GG; Wei W
    Sci Rep; 2015 Mar; 5():8865. PubMed ID: 25746010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput functional genomics using CRISPR-Cas9.
    Shalem O; Sanjana NE; Zhang F
    Nat Rev Genet; 2015 May; 16(5):299-311. PubMed ID: 25854182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Technology: Applications and Human Disease Modeling.
    Martinez-Lage M; Torres-Ruiz R; Rodriguez-Perales S
    Prog Mol Biol Transl Sci; 2017; 152():23-48. PubMed ID: 29150003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
    Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
    Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.